At the end of the treatment, BMI, waist circumference, waist-to-hip ratio, aspartate amino transferase (AST), alanine amino transferase (ALT), gamma-glutamyl transferase (GGT), high-density lipoproteins (HDL), low-density lipoproteins (LDL), triglycerides (TG), serum glucose, total-cholesterol/HDL ratio, LDL/HDL ratio, TG/HDL ratio, homeostatic model assessment-insulin resistance (HOMA-IR), the fatty liver index (FLI), the Kotronen index, and the fatty liver score all showed a significant improvements (p < 0.01) [25]. The gene discussed is GPT; the disease is Hepatic steatosis.